A parenteral injection. Acute allergic reactions; bronchial asthma and asthmatic status; prophylaxis or treatment of thyrotoxic reaction and thyrotoxic crisis; shock, incl. resistant to other therapies; myocardial infarction; acute adrenal insufficiency; cirrhosis of the liver, acute hepatitis, acute hepatic renal insufficiency; poisoning with cauterizing fluids (in order to reduce inflammatory phenomena and prevent scar contractions).
Pills. Systemic diseases of the connective tissue (systemic lupus erythematosus, scleroderma, nodular periarthritis, dermatomyositis, rheumatoid arthritis); acute and chronic inflammatory joint diseases: gouty and psoriatic arthritis, osteoarthritis (incl. post-traumatic), polyarthritis, shoulder periarthritis, ankylosing spondylitis (Bekhterev’s disease), juvenile arthritis, Still’s syndrome in adults, bursitis, nonspecific tenosynovitis, synovitis and epicondylitis; rheumatic fever, acute rheumocarditis; bronchial asthma; acute and chronic allergic diseases: allergic reactions to drugs and food, serum disease, hives, allergic rhinitis, angioedema, drug eczantema, pollinosis; skin diseases: vesicle, psoriasis, eczema, atopic dermatitis, diffuse neurodermatitis, contact dermatitis (with large skin surface lesions), toxidermia, seborrheic dermatitis, exfoliating dermatitis, toxic epidermal necrolysis (Lyell syndrome), bullous herpetiform dermatitis, malignant exudative erythema (Stevens-Johnson syndrome); cerebral edema. (e.g. against a brain tumour or associated with surgery, radiation therapy or head trauma) after prior parenteral administration; congenital adrenal hyperplasia; primary or secondary adrenal insufficiency (e.g. against a brain tumour or associated with surgery, radiation therapy or head trauma) after prior parenteral administration; congenital adrenal hyperplasia; primary or secondary adrenal insufficiency (e.g. against a brain tumour, associated with surgery, radiotherapy or head trauma). including condition after adrenal removal); kidney diseases of autoimmune genesis (including acute glomerulonephritis), nephrotic syndrome; subacute thyroiditis; diseases of the hematopoiesis organs: agranulocytosis, panmielopathy, autoimmune hemolytic anemia, congenital (erythroid) hypoplastic anemia, acute lympho- and myeloid leukemia, lymphogranulomatosis, myeloma, thrombocytopenic purpura, secondary thrombocytopenia in adults, erythroblastopenia (erythrocytic anemia); lung diseases: acute alveolitis, pulmonary fibrosis, sarcoidosis II-III centuries. Tuberculosis meningitis, tuberculosis of the lungs, aspiration pneumonia (in combination with specific chemotherapy); berylliosis, Leffler’s syndrome (not amenable to other therapy); lung cancer (in combination with cytostatics); multiple sclerosis; gastrointestinal tract diseases (to remove the patient from critical condition): ulcerative colitis, Crohn’s disease, local enteritis; hepatitis; prevention of the reaction of rejection of the graft; hypercalcemia against cancer; nausea and vomiting in cytostatic therapy; allergic eye diseases: allergic corneal ulcers, allergic forms of conjunctivitis; inflammatory eye diseases: sympathetic ophthalmia, severe sluggish anterior and posterior uveitis, optic neuritis.
Ointment: hives, atopic dermatitis, diffuse neurodermatitis, simple chronic lichen (limited neurodermatitis), eczema, seborrheic dermatitis, discoidal lupus erythematosus, simple and allergic dermatitis, toxicodermia, erythroderma, psoriasis, alopecia; epicondylitis, tendosynovitis, bursitis, brachial periarthritis, keloid scars, ischialgia.
Eye drops: non-inflammatory diseases of the anterior segment of the eye – iritis, iridocyclitis, uveitis, episcleritis, scleritis, conjunctivitis, parenchymatous and discoid keratitis without damaging the corneal epithelium, allergic conjunctivitis, blepharoconjunctivitis, inflammatory processes after eye injuries and surgical interventions, sympathetic ophthalmia.
Hypersensitivity (the only contraindication for short-term system applications is for life indications).